UCB INC FDA Approval NDA 021726

NDA 021726

UCB INC

FDA Drug Application

Application #021726

Documents

Letter2011-06-24
Label2005-01-26
Label2006-02-07
Label2011-06-16
Letter2005-01-26
Letter2006-02-07
Review2006-07-25

Application Sponsors

NDA 021726UCB INC

Marketing Status

Discontinued001
Discontinued002
Discontinued003
Discontinued004

Application Products

001TABLET, ORALLY DISINTEGRATING;ORAL0.25MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**1NIRAVAMALPRAZOLAM
002TABLET, ORALLY DISINTEGRATING;ORAL0.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**1NIRAVAMALPRAZOLAM
003TABLET, ORALLY DISINTEGRATING;ORAL1MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**1NIRAVAMALPRAZOLAM
004TABLET, ORALLY DISINTEGRATING;ORAL2MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**1NIRAVAMALPRAZOLAM

FDA Submissions

TYPE 3; Type 3 - New Dosage FormORIG1AP2005-01-19STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL6AP2006-02-06N/A
LABELING; LabelingSUPPL8AP2011-06-16STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL11AP2012-12-14STANDARD

Submissions Property Types

ORIG1Null31
SUPPL8Null6
SUPPL11Null0

CDER Filings

UCB INC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 21726
            [companyName] => UCB INC
            [docInserts] => ["",""]
            [products] => [{"drugName":"NIRAVAM","activeIngredients":"ALPRAZOLAM","strength":"0.25MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**","dosageForm":"TABLET, ORALLY DISINTEGRATING;ORAL","marketingStatus":"Discontinued","te":"None","rld":"Yes","rs":"No"},{"drugName":"NIRAVAM","activeIngredients":"ALPRAZOLAM","strength":"0.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**","dosageForm":"TABLET, ORALLY DISINTEGRATING;ORAL","marketingStatus":"Discontinued","te":"None","rld":"Yes","rs":"No"},{"drugName":"NIRAVAM","activeIngredients":"ALPRAZOLAM","strength":"1MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**","dosageForm":"TABLET, ORALLY DISINTEGRATING;ORAL","marketingStatus":"Discontinued","te":"None","rld":"Yes","rs":"No"},{"drugName":"NIRAVAM","activeIngredients":"ALPRAZOLAM","strength":"2MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**","dosageForm":"TABLET, ORALLY DISINTEGRATING;ORAL","marketingStatus":"Discontinued","te":"None","rld":"Yes","rs":"No"}]
            [labels] => [{"actionDate":"06\/16\/2011","submission":"SUPPL-8","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2011\\\/021726s008lbl.pdf\"}]","notes":""},{"actionDate":"02\/06\/2006","submission":"SUPPL-6","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2006\\\/021726s006lbl.pdf\"}]","notes":""},{"actionDate":"01\/19\/2005","submission":"ORIG-1","supplementCategories":"Approval","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2005\\\/021726lbl.pdf\"}]","notes":""}]
            [originalApprovals] => [{"actionDate":"NIRAVAM","submission":"ALPRAZOLAM","actionType":"0.25MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**","submissionClassification":"TABLET, ORALLY DISINTEGRATING;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">Yes"},{"actionDate":"NIRAVAM","submission":"ALPRAZOLAM","actionType":"0.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**","submissionClassification":"TABLET, ORALLY DISINTEGRATING;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">Yes"},{"actionDate":"NIRAVAM","submission":"ALPRAZOLAM","actionType":"1MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**","submissionClassification":"TABLET, ORALLY DISINTEGRATING;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">Yes"},{"actionDate":"NIRAVAM","submission":"ALPRAZOLAM","actionType":"2MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**","submissionClassification":"TABLET, ORALLY DISINTEGRATING;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">Yes"}]
            [supplements] => 
            [actionDate] => 2011-06-16
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.